Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Wondering about your retirement target at 40? Discover how to plan ahead for a secure financial future with our expert insights.
24,965 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Regulatory moves around AI can move crypto markets faster than a breakthrough in code. This piece explains what happe...
In June, gold and silver prices pulled back, pressuring Hycroft Mining, a Nevada-focused, single-mine precious metals...
When a top executive sells stock, investors want to know if it signals trouble or simply personal planning. This arti...
Ark Invest’s latest stance on quantum computing raises questions for Rigetti Computing. This guide breaks down the im...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
Rigetti Computing shares slid in a choppy week as inflation jitters and noisy peers weighed on sentiment. This guide ...
Discretionary travel names like these cruise line stocks are feeling the strain as fuel prices rise and traveler dema...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
When a space company announces a bold acquisition, investors sit up. This article breaks down what york space buys al...
Shoe Carnival's 2025 earnings season offers clues about margins, online growth, and store results. This guide breaks ...